Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Livius Penter(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Matthew Nazzaro(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan)), Jerome Ritz(Dana-Farber Cancer Institute), Aashna Jhaveri(Dana-Farber Cancer Institute), Corey Cutler(Harvard University), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Srinika Ranasinghe(Dana-Farber Cancer Institute), Haesook T. Kim(Dana-Farber Cancer Institute), Helen Chen(IQVIA (United States)), Philippe Armand(Harvard University), Joseph H. Antin(Dana-Farber Cancer Institute), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Kenneth J. Livak(Broad Institute), Carrie Cibulskis, Pavan Bachireddy(Broad Institute), Scott J. Rodig(Brigham and Women's Hospital), Stacey Gabriel(Broad Institute), Mariano Severgnini(Dana-Farber Cancer Institute), Matthew S. Davids(Dana-Farber Cancer Institute), Jingxin Fu(Tongji University), Robert J. Soiffer(Dana-Farber Cancer Institute), Xia Liu(Harvard University), Emily M. Thrash(Dana-Farber Cancer Institute), Shuqiang Li(Anhui Normal University), Sacha Gnjatic(Tisch Hospital), Nicoletta Cieri(Broad Institute), Teddy Huang(Dana-Farber Cancer Institute), F. Stephen Hodi(Harvard University), Wandi Zhang(Dana-Farber Cancer Institute), Howard Streicher(National Cancer Institute), Yi Zhang(Case Western Reserve University), Sarah Nikiforow(Otsuka (Japan)), Alexandra Savell(Dana-Farber Cancer Institute), Emma Hathaway(Dana-Farber Cancer Institute)
Blood
March 15, 2021
Cited by 42


Related Papers